Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avior Bio
Holly Springs / Cary, North Carolina, United Statesaviorbio.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
Avior Bio has developed the Speedit nanoparticle delivery platform, which is in clinical development through programs like AV104 for pruritus. The company emphasizes rapid onset, high bioavailability, and FDA-certified clinical manufacturing.
- Therapeutic areas
- NeurologyDermatology
- Modalities
- Small moleculeNanoparticleFilm-based drug deliveryInjectable
- Industry
- Biotech
02
Partnerships
Tharimmune Inc (collaborating on AV104 for pruritus)
Beyond the preview
Go deeper on Avior Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avior Bio.